Catalio Capital Management
New York-based investment firm focused on the full lifecycle of innovative healthcare investing across private, public, and credit markets.
Catalio Capital Management was founded in 2020, is headquartered in New York, United States, has 34 recorded investments, and includes 115 companies in its recorded portfolio.
- Headquarters
- New York, United States
- Founded
- 2020
- Website
- cataliocapital.com
- AUM
- $2.0B
- Portfolio Companies
- 115
- Total Investments
- 34
- Last Investment
- Aug 2026
- Geographic Focus
- United States, United Kingdom
Indexed holds 115 portfolio companies and 34 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Catalio Capital Management is a Venture Capital firm based in New York, United States. It was founded in 2020. It has made 34 investments, including Amalgam Rx, XRHealth and PrognomIQ. Focus areas include Artificial Intelligence and Biotech.
Portfolio115
Showing 48 of 115 recorded portfolio companies.
Co-investors24
Sign up to view co-investors
24 co-investors across 166 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×19 · Corporate VC ×2 · Hedge Fund ×2 · 33 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/catalio-capital-management"><img src="https://indexed.vc/api/badge/investor/catalio-capital-management" alt="Catalio Capital Management on Indexed.vc" width="260" height="76" /></a>